Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

ITM Solucin GmbH
Sponsor

ITM Solucin GmbH

Germany Lichtenbergstrasse 1, 85748, Germany

About the sponsor

Research activity is centred on somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours, including inoperable and progressive disease with a focus on progression-free survival and treatment response.

  • PRRT with lutetium Lu 177 edotreotide
  • Well-differentiated GEP-NET
  • Somatostatin receptor-positive tumours

The sponsor also studies aggressive Grade 2 and Grade 3 disease within this tumour group, reflecting a strong therapeutic interest in advanced neuroendocrine oncology.

About Specializations

ITM Solucin GmbH runs clinical trials in conditions such as Gastroenteropancreatic neuroendocrine tumour disease, Lymphoma, Neuroendocrine tumour, Gastrointestinal stromal tumour, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

3 clinical trials

Lymphoma+6

Recruiting

Study to Find the Right Dose and Safety of Lutetium (177Lu) Edotreotide and Arginine-Lysine in Children with Somatostatin Receptor-Positive Tumors

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:L-Arginine Hydrochloride
  • Sponsor:ITM Solucin GmbH

Gastroenteropancreatic neuroendocrine tumour disease

Not recruiting

Study comparing 177Lu-edotreotide versus everolimus in patients with inoperable progressive neuroendocrine tumors of gastroenteric or pancreatic origin

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Everolimus
  • Sponsor:ITM Solucin GmbH

Gastroenteropancreatic neuroendocrine tumour disease

Not recruiting

Study of Lutetium (177Lu) Edotreotide compared to standard treatment in patients with aggressive Grade 2 and Grade 3 gastroenteropancreatic neuroendocrine tumors (GEP-NETs)

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:ITM Solucin GmbH

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.